Repurchase of Truecaller B shares in week 9, 2024
The share buybacks form part of the share buyback programme announced by Truecaller on
On the Annual General Meeting 2023 the Board was authorized to buy back B-shares up until the Annual General Meeting in 2024. The new authorization means that buybacks may be made so that the company's shareholding does not exceed ten (10) percent of the total number of shares in the company outstanding as of the date of the annual general meeting.
Date: | Aggregated daily | Weighted average share | Total daily transaction |
48 868 | 28.29 | 1 382 310 | |
70 000 | 28.49 | 1 994 307 | |
115 000 | 28.63 | 3 292 117 | |
75 000 | 28.68 | 2 151 015 | |
150 000 | 28.06 | 4 209 435 | |
Total accumulated over | 458 868 | 28.39 | 13 029 183 |
Total accumulated | 12 812 292 | 32.38 | 414 816 456 |
All acquisitions have been carried out on Nasdaq Stockholm by Carnegie on behalf of Truecaller. Following the above acquisitions. Truecaller's holding of own shares amounts to 26,094,071 B shares and 5,600,000 C-shares as of
For more information, please contact:
+46 705 29 08 00
[email protected]
About Truecaller:
Truecaller (TRUE B) is the leading global platform for verifying contacts and blocking unwanted communication. We enable safe and relevant conversations between people and make it efficient for businesses to connect with consumers. Fraud and unwanted communication are endemic to digital economies. especially in emerging markets. We are on a mission to build trust in communication. Truecaller is an essential part of everyday communication for more than 374 million active users, with more than a billion downloads since launch and around 50 billion unwanted calls identified and blocked in 2022. Headquartered in
The following files are available for download:
Press release buybacks week 9 2024 Truecaller |
View original content:https://www.prnewswire.com/news-releases/repurchase-of-truecaller-b-shares-in-week-9-2024-302078255.html
SOURCE Truecaller AB
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Katten Expands Restructuring Practice with Addition of Genevieve Weiner
- Onco-Innovations Enters into LOI with Ifowonco for Exclusive Option and Worldwide Licence to LAG-3 Small-Molecule Inhibitor Program
- Ingenia Therapeutics Nominated for Both the Prix Galien USA and the Inaugural Prix Galien Korea for Best Startup
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share